Neuro-Ophthalmologic and Electroretinographic Findings in Pantothenate Kinase-Associated Neurodegeneration (formerly Hallervorden-Spatz Syndrome)

Swaiman, 1991, Hallervorden-Spatz syndrome and brain iron metabolism, Arch Neurol, 48, 1285, 10.1001/archneur.1991.00530240091029 Dooling, 1974, Hallervorden-Spatz syndrome, Arch Neurol, 30, 70, 10.1001/archneur.1974.00490310072012 Thomas, 2004, Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration, Mov Disord, 19, 36, 10.1002/mds.10650 Zhou, 2001, A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome, Nat Genet, 28, 345, 10.1038/ng572 Neumann, 2000, Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies, Acta Neuropathol (Berl), 100, 568, 10.1007/s004010000224 Sener, 2003, Pantothenate kinase-associated neurodegeneration, AJNR Am J Neuroradiol, 24, 1690 Sodeyama, 1993, [A case of Hallervorden-Spatz syndrome with marked atrophy of the brainstem and cerebellum], Rinsho Shinkeigaku, 33, 525 Weleber, 1981, The effect of age on human cone and rod ganzfeld electroretinograms, Invest Ophthalmol Vis Sci, 20, 392 Weleber, 1998, The dystrophic retina in multisystem disorders, Eye, 12, 580, 10.1038/eye.1998.148 Weleber, 1988, Retinal function and physiological studies, 21 Marmor, 1995, Standard for clinical electroretinography (1994 update), Doc Ophthalmol, 89, 199, 10.1007/BF01203373 Hayflick, 2003, Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome, N Engl J Med, 348, 33, 10.1056/NEJMoa020817 Battistella, 1998, Optic atrophy as the first symptom in Hallervorden-Spatz syndrome, Childs Nerv Syst, 14, 135, 10.1007/s003810050196 Feliciani, 1994, Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease, Neuroradiology, 36, 247, 10.1007/BF00588145 Hickman, 2001, How broad is the phenotype of Hallervorden-Spatz disease?, Acta Neurol Scand, 103, 201, 10.1034/j.1600-0404.2001.103003201.x Koeppen, 2001, Iron in the Hallervorden-Spatz syndrome, Pediatr Neurol, 25, 148, 10.1016/S0887-8994(01)00269-7 Porter-Grenn, 1993, Hallervorden-Spatz disease with bilateral involvement of globus pallidus and substantia nigra, J Comput Assist Tomogr, 17, 961, 10.1097/00004728-199311000-00019 Tripathi, 1992, Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome, Acta Neuropathol (Berl), 83, 113, 10.1007/BF00308470 Berson, 1980, Risk factors for genetic typing and detection in retinitis pigmentosa, Am J Ophthalmol, 89, 763, 10.1016/0002-9394(80)90163-4 Heckenlively, 1982, The frequency of posterior subcapsular cataract in the hereditary retinal degenerations, Am J Ophthalmol, 93, 733, 10.1016/0002-9394(82)90469-X Egan, 2000, Posterior subcapsular cataract in Degos disease, Am J Ophthalmol, 129, 806, 10.1016/S0002-9394(00)00460-8 Luckenbach, 1983, Ocular clinicopathologic correlation of Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy, Am J Ophthalmol, 95, 369, 10.1016/S0002-9394(14)78308-4 Heckenlively, 1988, 68 Weleber, 2001, Retinitis pigmentosa and allied disorders, 362 Heckenlively, 1981, Telangiectasia and optic atrophy in cone-rod degenerations, Arch Ophthalmol, 99, 1983, 10.1001/archopht.1981.03930020859009